# Effect of TXA on Blood Loss in Reverse Total Shoulder Arthroplasty

> **NCT06638749** · PHASE3 · WITHDRAWN · sponsor: **University of Kansas Medical Center**

## Conditions studied

- Shoulder Arthritis
- Blood Loss, Surgical
- Tranexamic Acid Adverse Reaction

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT06638749
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-05-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2024-10-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Administrative withdrawal-study not approved by IRB
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06638749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06638749, "Effect of TXA on Blood Loss in Reverse Total Shoulder Arthroplasty". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06638749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*